title: The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. Sandoz/CVIS Investigators.
authors.affiliation: St. Louis University Health Sciences Center, MO 63110, USA.
authors.forename: L
authors.initials: L
authors.lastname: Miller
authors.forename: J
authors.initials: J
authors.lastname: Kobashigawa
authors.forename: H
authors.initials: H
authors.lastname: Valantine
authors.forename: H
authors.initials: H
authors.lastname: Ventura
authors.forename: P
authors.initials: P
authors.lastname: Hauptman
authors.forename: J
authors.initials: J
authors.lastname: O'Donnell
authors.forename: J
authors.initials: J
authors.lastname: Wiedermann
authors.forename: A
authors.initials: A
authors.lastname: Yeung
mesh_terms: D000328:Adult; D000368:Aged; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology; D012189:Retrospective Studies; D012307:Risk Factors; D017539:Tunica Intima / Q000000981:diagnostic imaging / Q000187:drug effects / Q000276:immunology; D018084:Ultrasonography, Interventional
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine